Stay updated on TAK-861 in Narcolepsy Type 1 Clinical Trial
Sign up to get notified when there's something new on the TAK-861 in Narcolepsy Type 1 Clinical Trial page.

Latest updates to the TAK-861 in Narcolepsy Type 1 Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoNo Change Detected
- Check21 days agoChange DetectedThe website’s revision tag updated from Revision: v3.5.3 to Revision: v3.5.4, indicating a patch-level update. The old revision text was removed and the new one is now displayed to reflect the change.SummaryDifference0.0%

- Check28 days agoNo Change Detected
- Check35 days agoChange DetectedThe page revision label was updated from v3.5.2 to v3.5.3. This reflects a newer version of the page's metadata rather than a substantive content change.SummaryDifference0.0%

- Check50 days agoChange DetectedThe page’s revision tag updated from v3.5.0 to v3.5.2.SummaryDifference0.0%

- Check78 days agoChange DetectedRevision: v3.5.0 has been added. Revision: v3.4.3 has been removed.SummaryDifference0.0%

- Check85 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3.SummaryDifference0.0%

- Check93 days agoChange DetectedAdded the 2026 JAMA Neurology citation for Oveporexton and removed the 2025 ahead-of-print citation for the same article.SummaryDifference0.0%

Stay in the know with updates to TAK-861 in Narcolepsy Type 1 Clinical Trial
Enter your email address, and we'll notify you when there's something new on the TAK-861 in Narcolepsy Type 1 Clinical Trial page.